| Patient | Natsume Sōseki |
|---|---|
| Date of birth | 1983-02-09 |
| Identifiers | MRN HR-ET023-SYN; SSN (made up) 000-23-8840 |
| Document date | 2026-05-21 |
| Author | Haruka Lindqvist-Mori, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Three-day review, with upper endoscopy by gastroenterology this morning. [S]
Mr. Natsume returns three days after his first visit and had an upper endoscopy this morning with Dr. Abrahamsen-Ito of gastroenterology. Since his first visit he has stopped ibuprofen and taken acetaminophen twice for headache. The epigastric pain continues, gnawing before meals and waking him at night, and is eased by food. His stools have been brown, with no further black stools since ten days before his first visit, and he has not vomited blood or felt faint. He fasted for the endoscopy and has recovered from the sedation. [S]
| Element | Detail |
|---|---|
| Symptoms | Epigastric pain unchanged; no further black stools; no vomiting or fainting |
| Medicines | Ibuprofen stopped; acetaminophen twice |
| Testing today | Upper endoscopy with biopsies and a rapid urease test; hemoglobin |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired; no fever or weight loss |
| Gastrointestinal | Positive | Epigastric pain before meals and at night; brown stools; no vomiting |
| Cardiovascular | Negative | No lightheadedness or fainting |
| Psychiatric | Positive | Worried about cancer; no low mood or thoughts of self-harm |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 500 mg oral tablet, one or two tablets by mouth every six hours as needed for headache or pain, no more than 3 g a day (in place of ibuprofen) | One or two tablets every six hours as needed; no more than six tablets a day | Oral route | 2026-05-18 | active | S |
| Vonoprazan 20 mg oral tablet, one tablet by mouth each morning for eight weeks for gastric ulcer healing | One tablet each morning for eight weeks | Oral route | 2026-05-21 to 2026-07-16 | completed | S |
| Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth every other day | One tablet every other morning | Oral route | 2026-05-21 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-05-21 | Body height | 159 | cm | S |
| 2026-05-21 | Body weight | 51.8 | kg | S |
| 2026-05-21 | Body mass index (BMI) [Ratio] | 20.5 | kg/m2 | S |
| 2026-05-21 | Systolic blood pressure | 122 | mm[Hg] | S |
| 2026-05-21 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-05-21 | Heart rate | 82 | /min | S |
| 2026-05-21 | Respiratory rate | 14 | /min | S |
| 2026-05-21 | Body temperature | 36.5 | Cel | S |
| 2026-05-21 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-05-21 | Hemoglobin [Mass/volume] in Blood | 11 | g/dL | 13.2-17.1 g/dL | Low | S |
Vital signs recorded on 2026-05-21; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Alert after light sedation; pale; weight 51.8 kg; pulse 82, blood pressure 122/76 |
| Abdomen | Mild epigastric tenderness; no guarding, mass or enlarged liver |
| Rectal | Deferred; stools brown by history and at endoscopy no fresh blood in the stomach |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| About three weeks of gnawing epigastric pain, worse before meals and at night and eased by food, with two episodes of black, tarry stools ten days ago and iron-deficiency anemia; stable, Glasgow-Blatchford score 4; peptic ulcer suspected and urgent endoscopy booked | resolved | confirmed | R10.13 | S — Synthetic presenting concern at the index visit, superseded by the diagnosis at endoscopy; its timing echoes his documented stomach illness of May 1910 (D). |
| Gastric ulcer, 15 mm, on the lesser curvature at the angulus, with recent bleeding (melena) and a clean base at endoscopy (Forrest III); margin biopsies benign; Helicobacter pylori positive; synthetic modern diagnosis for his documented gastric ulcer | active | confirmed | K25.4 | S — Synthetic modern diagnosis anchored to his documented gastric ulcer (D); the Helicobacter pylori cause is synthetic. |
| Helicobacter pylori infection (rapid urease test and histology positive; clarithromycin resistance mutation on biopsy PCR) | active | confirmed | B96.81 | S — Synthetic finding at endoscopy; no historical claim is made about the organism in his illness. |
| Iron-deficiency anemia from chronic blood loss (hemoglobin 11.2 g/dL, MCV 76 fL, ferritin 8 ng/mL) | active | confirmed | D50.0 | S — Synthetic finding at intake. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Imaging | Upper endoscopy with biopsy of the ulcer margin | At diagnosis; repeat for a gastric ulcer at 8 to 12 weeks to confirm healing and biopsy the scar | Completed today | 15 mm clean-based gastric ulcer at the angulus (Forrest III); six margin biopsies sent |
| Laboratory | Helicobacter pylori test (rapid urease test and histology) with clarithromycin-resistance testing | At diagnosis, before any acid suppression or antibiotic | Completed today | Rapid urease test positive; histology and clarithromycin-resistance PCR sent |
| Laboratory | Hemoglobin before endoscopy | At endoscopy for a recent bleed | Completed today | 11.0 g/dL, stable from 11.2 |
| Medication safety | Acid suppression for ulcer healing (vonoprazan) | Daily for eight weeks for a gastric ulcer | Completed today | Vonoprazan 20 mg each morning started after the biopsies |
| Medication safety | NSAID avoidance | Every visit | Completed today | Ibuprofen stopped at the first visit; none since |
| Self-management | Bleeding warning signs and when to call 119 | Every visit | Completed today | No new black stools; warning signs and 119 reviewed |
| Self-management | Alcohol, smoking and meals | Every visit | Completed today | Does not smoke; alcohol rarely; regular meals advised |
| Medication safety | Oral iron | From the day the source is found | Completed today | Ferrous sulfate every other morning started today |
| Survey | Stress and depression: PHQ-9 and GAD-7 | At intake and at the end of the episode | Up to date | PHQ-9 7 and GAD-7 8 three days ago |
| Referral | Gastroenterology consultation and endoscopy | Within three days for a recent ulcer bleed | Completed today | Seen by Dr. Abrahamsen-Ito this morning |
Goal progress:
Guideline basis: ACG Clinical Guideline: Treatment of Helicobacter pylori Infection (2024); Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report (2022); Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition (2016 (published 2019)); Evidence-based clinical practice guidelines for peptic ulcer disease 2026 (2026); ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding (2021); CMID: Clinical Monitoring Intelligence Database, anemia monograph (2026)
Follow-up: Two-week visit with the biopsy results, the resistance result, the eradication plan and a hemoglobin. Call 119 for black, tarry stools, vomiting blood or fainting. Next scheduled visit 2026-06-04: two-week review: biopsy results, Helicobacter pylori resistance testing, and start of eradication therapy. [S]